← Back to headlines
Collegium to Acquire ADHD Medicine Azstarys for Up to $785 Million
Collegium Pharmaceutical plans to acquire the ADHD medication Azstarys in a deal valued at up to $785 million, expanding its portfolio in the neuroscience therapeutic area.
19 Mar, 12:41 — 19 Mar, 12:41
Sources
Showing 1 of 1 sources
